AIM2 and colorectal carcinoma: Several research revealed that AIM2 inhibits the proliferation of CRC cells by interacting with DNA-dependent protein kinase DNA-PK (74, 75) or triggering cell cycle arrest (Figure 3, left panels) (10, 72, 76).